fda650708be9aa8e1fb0400a50e51644:ba7127b2f3446b9c59efb5b2244be4b3218e762434d946e24293ba6f24d9549d28b66f3ff1ebeae79adb32eb69830f91935ea14610006d9c347200caea28cba2a36e87540d3a86d178ab489554231b7b6ba5d43386b883119da5cb1fb2cdb0e096fca7372da6b2bb939378c40930be4006410cd4c70ee56f70d8ccb398871b290b811d1d6b9eea037534fa6522f2f072341e4a13b7e65fce23979bd2d8787e02aee10ee68b606694cbbe3548fe52079c27d057df8f847a4cc4d6a90ee9eeed391b6ec2def57c1ea2919cc5f477e8c5b71e4110668a19693f1b5abfcb729d10f1058410380ea9f04a72df5420d40197ecac3dcd32d05cb428b1db3af5f10832e8977ed11df698c437553c8c5d9f3f70fdbcd3533295a2e3a118658158e609c5da65f094f16d2b05053f8e724d80e875340c73f20714e9b181ccae861d242be8835957de08179b72e5fb6e3485621d5304f840b092ad0a0e1920e3c12fc8a8c777e8c49db29207ad17ddee625249d0a035be96dc8f458d3994a8bf4ac0fe332a9607c21f6bcdc039a685bcd06f5946550b09959df1b6caebc8ba6877dd